<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="lead">
            <roleset id="lead.01" name="resulted&#x0A;" wordnet="3">
                <roles>
                    <role n="0" descr="factors&#x0A;" />
                    <role n="2" descr="result&#x0A;" />
                </roles>
                <example src="PERMUTATE" no="0">
                    <text>Crl stimulates sigma (S) activity is able to lead to an increase in the rate of transcription of a subset of rpoS regulon genes in the stationary phase.</text>
                    <arg n="0">Crl stimulates sigma (S) activity</arg>
                    <arg n="1">an increase in the rate of transcription of a subset of rpoS regulon genes in the stationary phase</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>Crl stimulates sigma activity (S) is able to lead an increase in the transcription rate of a subset of rpoS regulatory genes in the stationary phase (picture 3A).</text>
                    <arg n="0">Crl stimulates sigma activity (S)</arg>
                    <arg n="1">an increase in the transcription rate of a subset of rpoS regulatory genes in the stationary phase</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>Crl stimulates sigma activity (S) is able to lead to an increase in the rate of transcription of a subset of rpoS genes in the stationary phase (figure 3A).</text>
                    <arg n="0">Crl stimulates sigma activity (S)</arg>
                    <arg n="1">an increase in the rate of transcription of a subset of rpoS genes in the stationary phase</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>The Crl stimulates sigma activity (S) leads to an increase in the transcription rate of a subset of rpoS regulatory genes in the stationary phase.</text>
                    <arg n="0">Crl stimulates sigma activity (S)</arg>
                    <arg n="1">an increase in the transcription rate of a subset of rpoS regulatory genes in the stationary phase</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>The a C---A transversion in the helix sequence of the last intron of the only ERCC-3 allele will lead to an insertion of 4 bp into the mRNA and an inactivating frame shift in the proteins terminal C.</text>
                    <arg n="0">a C---A transversion in the helix sequence of the last intron of the only ERCC-3 allele</arg>
                    <arg n="1">an insertion of 4 bp into the mRNA and an inactivating frame shift in the proteins terminal C</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>The a point mutation at the application site of the third intron leads to the ligation of the second to the fourth exon appears to be one of the causes of X-linked recessive adreoleukodrophite.</text>
                    <arg n="0">a point mutation at the application site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>The closer to the transduction pathway of the putative signal that modulates the htrA transcription leads to the identification of two new genes.</text>
                    <arg n="0">closer to the transduction pathway of the putative signal that modulates the htrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>The mutations identified include: Crl stimulates sigma activity (S) that led to an increase in the transcription rate of a subset of regulatory rpoS genes in the stationary phase, two of them involving amino acids within the transmembrane putative domains.</text>
                    <arg n="0">Crl stimulates sigma activity (S)</arg>
                    <arg n="1">an increase in the transcription rate of a subset of regulatory rpoS genes in the stationary phase</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>The mutations identified include: GATA-4 co-transfection with MEF2A, MEF2C or MEF2D leading to a synergistic activation of 40 to 50 folds of the promoter ANA, two of them involving amino acids located in putative transmembranous domains.</text>
                    <arg n="0">GATA-4 co-transfection with MEF2A, MEF2C or MEF2D</arg>
                    <arg n="1">a synergistic activation of 40 to 50 folds of the promoter ANA</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>The mutations identified include: a mutation point (GTC---ATC) in codon 383 that led to the conservative substitution of isoleucine by valine in the putative fifth extracellular transporter loop, two of them involving amino acids located in putative transmembrane domains.</text>
                    <arg n="0">a mutation point (GTC---ATC) in codon 383</arg>
                    <arg n="1">the conservative substitution of isoleucine by valine in the putative fifth extracellular transporter loop</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>The transduction of the sea region from a sea strain, but not from a wild strain, leads to loss of OmpF.</text>
                    <arg n="0">loss of OmpF</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>These data suggest that GM2 genetic deficiency was able to lead to a neurological disorder that works to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">GM2 genetic deficiency</arg>
                    <arg n="1">a neurological disorder</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>This base pair G:C is also the strongest determinant in a closer examination of the transduction pathway of putative signals that modulates the transcription htrA leading to the identification of two new genes (Lagrange et al., 1998).</text>
                    <arg n="0">a closer examination of the transduction pathway of putative signals that modulates the transcription htrA</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>This base pair G:C is also the strongest determinant in a punctual mutation (GTC----ATC) in codon 383 that has led to conserved replacement of isoleucine by valine in the putative fifth extracellular loop of the transporter (Lagrange et al., 1998).</text>
                    <arg n="0">a punctual mutation (GTC----ATC) in codon 383</arg>
                    <arg n="1">conserved replacement of isoleucine by valine in the putative fifth extracellular loop of the transporter</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>This basic pair G:C is also the strongest determinant in Crl stimulates sigma activity (S) that leads to an increase in the transcription rate of a subset of regulatory rpoS genes in the stationary phase (Lagrange et al., 1998).</text>
                    <arg n="0">Crl stimulates sigma activity (S)</arg>
                    <arg n="1">an increase in the transcription rate of a subset of regulatory rpoS genes in the stationary phase</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>This basic pair G:C is also the strongest determinant in a C----A transversion following the last intron sneezing aceptor of the only ERCC-3 allele leading to an insertion of 4 bp into RNAm and an inactivating frameshift into the C-thermoid of the protein (Lagrange et al., 1998).</text>
                    <arg n="0">a C----A transversion following the last intron sneezing aceptor of the only ERCC-3 allele</arg>
                    <arg n="1">an insertion of 4 bp into RNAm and an inactivating frameshift into the C-thermoid of the protein</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>This can lead to synergistic activation of ANA and other target promoters of MEF2 (figuration 3A).</text>
                    <arg n="0">This</arg>
                    <arg n="1">synergistic activation of ANA and other target promoters of MEF2</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>This data suggests that Crl stimulates sigma activity (S) will lead to an increase in the transcription rate of a subset of rpoS genes in the stationary phase that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">Crl stimulates sigma activity (S)</arg>
                    <arg n="1">an increase in the transcription rate of a subset of rpoS genes in the stationary phase</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>This data suggests that DNA (nCaRE)-ref1 led to C2+ and transcriptional deletion that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">DNA (nCaRE)-ref1</arg>
                    <arg n="1">C2+ and transcriptional deletion</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>This data suggests that G979A affects a consensual site of the slice at the end of exon 8, and G1488T at exon 14 can lead to a substitution of a positive load in a highly conserved transmembrane domain (R496S) that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">G979A affects a consensual site of the slice at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a substitution of a positive load in a highly conserved transmembrane domain (R496S)</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>This data suggests that G979A affects a consensual site of the slice at the end of exon 8, and G1488T at exon 14 will lead to a substitution of a positive load in a highly conserved transmembrane domain (R496S) that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">G979A affects a consensual site of the slice at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a substitution of a positive load in a highly conserved transmembrane domain (R496S)</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>This data suggests that GM2 genetic deficiency was able to lead to a neurological disorder that works to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">GM2 genetic deficiency</arg>
                    <arg n="1">a neurological disorder</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>This data suggests that a closer examination of the transduction pathway of putative signals that modulates the HtrA transcription will lead to the identification of two new genes that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">a closer examination of the transduction pathway of putative signals that modulates the HtrA transcription</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>This data suggests that mutation of cut at 5 ends of the intron 5 was able to lead to abnormal exon 5 and portion of exon 6 that works to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">mutation of cut at 5 ends of the intron 5</arg>
                    <arg n="1">abnormal exon 5 and portion of exon 6</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>This data suggests that phosphorylation of MuSK NPXY site was able to lead to recruitment of a domain protein bound to phosphotyrosine that works to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">phosphorylation of MuSK NPXY site</arg>
                    <arg n="1">recruitment of a domain protein bound to phosphotyrosine</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>This data suggests that phosphorylation of the NPXY site of MuSK has led to recovery of a domain protein bound to phosphotyrosine that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">phosphorylation of the NPXY site of MuSK</arg>
                    <arg n="1">recovery of a domain protein bound to phosphotyrosine</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>This data suggests that the closest test to the putative signal transduction pathway that modulates the htrA transcription was able to lead to identification of two new genes that works to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">the closest test to the putative signal transduction pathway that modulates the htrA transcription</arg>
                    <arg n="1">identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>This is able to lead synergistic activation of ANA and other target promoters of MEF2 (picture 3A).</text>
                    <arg n="0">This</arg>
                    <arg n="1">synergistic activation of ANA and other target promoters of MEF2</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>This patient DNA contains genetic deficiency of the GM2 activator which leads to a neurological disease.</text>
                    <arg n="0">genetic deficiency of the GM2 activator</arg>
                    <arg n="1">a neurological disease</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>This was caused by This that leads to a wide diversity of nebulin and nebule isoforms.</text>
                    <arg n="0">This</arg>
                    <arg n="1">a wide diversity of nebulin and nebule isoforms</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>This was caused by a closer examination of the transfer pathway of putative signals that modulates the transcription htrA which led to the identification of two new genes.</text>
                    <arg n="0">a closer examination of the transfer pathway of putative signals that modulates the transcription htrA</arg>
                    <arg n="1">the identification of two new genes</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>This was caused by a point mutation at the pulse site of the third intron which has led to ligation of the second to the fourth exon.</text>
                    <arg n="0">a point mutation at the pulse site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>This was caused by phosphorylation of the site NPXY MuSK leading to recovery of a domain protein bound to phosphorosine.</text>
                    <arg n="0">phosphorylation of the site NPXY MuSK</arg>
                    <arg n="1">recovery of a domain protein bound to phosphorosine</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>a C--A transversion after the last intron sternalization aceptors of the ERCC-3 has led in an insertion of 4 bp into the mRNA and an inactivating frame shift in the proteins C-termoid.</text>
                    <arg n="0">a C--A transversion after the last intron sternalization aceptors of the ERCC-3</arg>
                    <arg n="1">an insertion of 4 bp into the mRNA and an inactivating frame shift in the proteins C-termoid</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>a mutation point (GTC---ATC) in codon 383 has led in the conservative substitution of isoleukin by valine in the putative fifth extracellular transporter loop, an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB).</text>
                    <arg n="0">a mutation point (GTC---ATC) in codon 383</arg>
                    <arg n="1">the conservative substitution of isoleukin by valine in the putative fifth extracellular transporter loop</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>a mutation point (GTC---ATC) in codon 383 led to the conservative substitution of isoleukin by valine in the putative fifth extracellular transporter loop.</text>
                    <arg n="0">a mutation point (GTC---ATC) in codon 383</arg>
                    <arg n="1">the conservative substitution of isoleukin by valine in the putative fifth extracellular transporter loop</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>a point mutation at the application site of the third intron is able to lead ligation of the second to the fourth exon (picture 3A).</text>
                    <arg n="0">a point mutation at the application site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>a point mutation at the pulse site of the third intron will lead to ligation of the second to the fourth exon coding an enzyme IITre of PTS for trehalose and the TreC coding enzyme TreC, cytoplasmic trehalose-6-phosphate-hydroxylase.</text>
                    <arg n="0">a point mutation at the pulse site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>an insertion of 4 bp into RNAm and an inactivating frameshift into the C-thermoid of the protein is led to a C----A transversion following the last intron sneezing aceptor of the only ERCC-3 allele.</text>
                    <arg n="0">a C----A transversion following the last intron sneezing aceptor of the only ERCC-3 allele</arg>
                    <arg n="1">an insertion of 4 bp into RNAm and an inactivating frameshift into the C-thermoid of the protein</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>conservative substitution of isoleucine for valine in the transporters fifth extracellular putative loop is led to a point mutation (GTC---ATC) in codon 383.</text>
                    <arg n="0">a point mutation (GTC---ATC) in codon 383</arg>
                    <arg n="1">conservative substitution of isoleucine for valine in the transporters fifth extracellular putative loop</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>cut switch at 5 ends of the intron 5 may lead to abnormal exon 5 and exon 6 (figure 3A).</text>
                    <arg n="0">cut switch at 5 ends of the intron 5</arg>
                    <arg n="1">abnormal exon 5 and exon 6</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>genetic deficiency of the GM2 activator is able to lead to a neurological disorder.</text>
                    <arg n="0">genetic deficiency of the GM2 activator</arg>
                    <arg n="1">a neurological disorder</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>growth of scherichia coli in the presence of nitrate or nitrite can lead to a 45% drop in expression (figuration 3A).</text>
                    <arg n="0">growth of scherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% drop in expression</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>normal exon 5 and portion of exon 6 was led by cut switch at 5 ends of the intron 5.</text>
                    <arg n="0">cut switch at 5 ends of the intron 5</arg>
                    <arg n="1">normal exon 5 and portion of exon 6</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>phosphorylation of MuSK NPXY site leads to recruitment of a domain protein bound to phosphotyrosine coding an enzyme IITre of PTS for trealose and the TreC coding enzyme TreC, cytoplasmic trealose-6-phosphate-hydroxylase.</text>
                    <arg n="0">phosphorylation of MuSK NPXY site</arg>
                    <arg n="1">recruitment of a domain protein bound to phosphotyrosine</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>phosphorylation of the site NPXY MuSK leading to recovery of a domain protein bound to phosphotyrosine, an atypical form of Tay-Sachs disease (gM2 variant AB lymphosidosis).</text>
                    <arg n="0">phosphorylation of the site NPXY MuSK</arg>
                    <arg n="1">recovery of a domain protein bound to phosphotyrosine</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>phosphorylation of the site NPXY MuSK may lead to recovery of a domain protein bound to phosphotyrosine.</text>
                    <arg n="0">phosphorylation of the site NPXY MuSK</arg>
                    <arg n="1">recovery of a domain protein bound to phosphotyrosine</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>recruitment of a domain protein bound to phosphotyrosine was led to phosphorylation of MuSK NPXY site.</text>
                    <arg n="0">phosphorylation of MuSK NPXY site</arg>
                    <arg n="1">recruitment of a domain protein bound to phosphotyrosine</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>the sequence selection experiment is leading to the identification of BRE.</text>
                    <arg n="0">the sequence selection experiment</arg>
                    <arg n="1">the identification of BRE</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>this can lead to a substantial diversity of isoforms of nebulin and nebulae, an atypical form of Tay-Sachs disease (gM2 variant of limphosis AB).</text>
                    <arg n="0">this</arg>
                    <arg n="1">a substantial diversity of isoforms of nebulin and nebulae</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>this led to a substantial diversity of isoforms of nebulin and nebulette (figuration 3A).</text>
                    <arg n="0">this</arg>
                    <arg n="1">a substantial diversity of isoforms of nebulin and nebulette</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>7 absent mutations, 2 mutations basic pair G:C is also the strongest determinant in This that leads to shifting in frames (Lagrange et al., 1998).</text>
                    <arg n="0">7 absent mutations, 2 mutations</arg>
                    <arg n="1">shifting in frames</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>7 absent mutations, 2 mutations led to shifting in frames (figuration 3A).</text>
                    <arg n="0">7 absent mutations, 2 mutations</arg>
                    <arg n="1">shifting in frames</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>7 mutations without sense, 2 mutations may lead to table transfer (figure 3A).</text>
                    <arg n="0">7 mutations without sense, 2 mutations</arg>
                    <arg n="1">table transfer</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>G979A affected a consensus site of the splice at the end of exon 8, and G1488T at exon 14 was caused by This that led to a substitution of a positive charge in a highly conserved transmembrane domain (R496S).</text>
                    <arg n="0">G979A affected a consensus site of the splice at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a substitution of a positive charge in a highly conserved transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>G979A affects a splice consensus site at the end of exon 8, and G1488T at exon 14 led to a substitution of a positive load in a highly conserved transmembrane domain (R496S) (figuration 3A).</text>
                    <arg n="0">G979A affects a splice consensus site at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a substitution of a positive load in a highly conserved transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>In addition, experiments with an antisense cDNA DNA expression vector introduced in cultivated cells suggest that the interaction disorganization of the SNU246 gene in the yeast leads to in vivo splicing defect, indicating that the protein is essential for splicing.</text>
                    <arg n="0">disorganization of the SNU246 gene in the yeast</arg>
                    <arg n="1">in vivo splicing defect, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>In addition, experiments with an antisense cDNA DNA expression vector introduced in cultivated cells suggest that the interaction inactivation of the MEF2C gene leads to morphogenetic cardiac defects, vascular abnormalities and mortality at day 9.5 embryonic.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and mortality at day 9.5 embryonic</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>In growth of Escherichia coli in the presence of nitrate or nitrite homologous part of the genes, GBP does not have an exon due to this, which inactivates the pulse segmentation event and leads to a 45% decrease in expression.</text>
                    <arg n="0">growth of Escherichia coli in the presence of nitrate or nitrite</arg>
                    <arg n="1">a 45% decrease in expression</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>The 7 mutations without sense, 2 mutations will lead to table transfer.</text>
                    <arg n="0">7 mutations without sense, 2 mutations</arg>
                    <arg n="1">table transfer</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>The 7 senseless mutations, 2 mutations led to the frame shift appears to be one of the causes of X-linked recessive adreoleukodrophite.</text>
                    <arg n="0">7 senseless mutations, 2 mutations</arg>
                    <arg n="1">frame shift</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>The G979A affected a consensus site of the splice at the end of exon 8, and G1488T at exon 14 led to the a positive replacement of a positive charge in a highly conserved transmembrane domain (R496S) appears to be one of the causes of X-linked recessive adreoleukodrophite.</text>
                    <arg n="0">G979A affected a consensus site of the splice at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a positive replacement of a positive charge in a highly conserved transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>The mutations identified include: G979A affected a consensus site of the splice at the end of exon 8, and G1488T at exon 14 that led to a positive replacement of a positive charge in a highly conserved transmembrane domain (R496S), two of them involving amino acids located in putative transmembrane domains.</text>
                    <arg n="0">G979A affected a consensus site of the splice at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a positive replacement of a positive charge in a highly conserved transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>The mutations identified include: inactivation of the MEF2C gene leading to morphogenetic cardiac defects, vascular abnormalities, and death on the 9.5 embryos, two of them involving amino acids located in putative transmembranous domains.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities, and death on the 9.5 embryos</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>The transduction of the MarA region from a sea strain, but not from a wild strain, will lead to inactivation of the MEF2C gene.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>These data suggest that a point mutation at the application site of the third intron may lead to ligation of the second to the fourth intron that works to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">a point mutation at the application site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth intron</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>This DNA of patients contains inactivation of the MEF2C gene allele that can lead to morphogenetic cardiac defects, vascular abnormalities and lethality per embryonic day 9.5.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and lethality per embryonic day 9.5</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>This DNA of patients contains the 5-end mutation of the intron 5 that led to abnormal portion in exon 5 and exon 6.</text>
                    <arg n="0">the 5-end mutation of the intron 5</arg>
                    <arg n="1">abnormal portion in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>This DNA of patients contains the distinct termini amino acid allele that can lead to the direction of individual VDAC isoforms to different cellular compartments.</text>
                    <arg n="0">the distinct termini amino acid</arg>
                    <arg n="1">the direction of individual VDAC isoforms to different cellular compartments</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>This base pair G:C is also the strongest determinant in inactivation of the MEF2C gene that has led to morphogenetic cardiac defects, vascular abnormalities and mortality by day 9.5 embryo (Lagrange et al., 1998).</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and mortality by day 9.5 embryo</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>This basic pair G:C is also the strongest determinant in two frame shifts and a mutation of the splice site that leads to shortened OA1 proteins; removal of a threonine codon at position 290; and four opposite-sense mutations (Lagrange et al., 1998).</text>
                    <arg n="0">two frame shifts and a mutation of the splice site</arg>
                    <arg n="1">shortened OA1 proteins; removal of a threonine codon at position 290; and four opposite-sense mutations</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>This data suggests that inactivation of the MEF2C gene was able to lead to morphogenetic cardiac defects, vascular abnormalities and mortality at day 9.5 embryonic that works to stimulate phosphorylation and clustering of AchRs.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and mortality at day 9.5 embryonic</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>This data suggests that the mutation of the splice at 5 ends of the intron 5 led to the splice in exon 5 and exon 6 that works to stimulate phosphorylation and AchRs grouping.</text>
                    <arg n="0">the mutation of the splice at 5 ends of the intron 5</arg>
                    <arg n="1">the splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>This patient DNA contains the distinct termini amino acid which leads to the direction of individual VDAC isoforms to different cellular compartments.</text>
                    <arg n="0">the distinct termini amino acid</arg>
                    <arg n="1">the direction of individual VDAC isoforms to different cellular compartments</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>This was caused by 7 absent mutations, 2 mutations that may lead to shifting in frames.</text>
                    <arg n="0">7 absent mutations, 2 mutations</arg>
                    <arg n="1">shifting in frames</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>This was caused by a complex coupling site mutation which leading to an altered ARNJ1 resulting in a premature stop codon.</text>
                    <arg n="0">a complex coupling site mutation</arg>
                    <arg n="1">an altered ARNJ1 resulting in a premature stop codon</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>This was caused by a point mutation at the application site of the third intron that may lead to ligation of the second to the fourth intron.</text>
                    <arg n="0">a point mutation at the application site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth intron</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>This was caused by inactivation of the MEF2C gene leads to morphogenetic cardiac defects, vascular abnormalities and mortality on the 9.5 embryonic day.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and mortality on the 9.5 embryonic day</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>This was caused by inactivation of the MEF2C gene which has led to morphogenetic cardiac defects, vascular abnormalities and mortality on the 9.5 embryonic day.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and mortality on the 9.5 embryonic day</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>This was caused by two frameshifts and a splice site mutation that can lead to truncated proteins of OA1; a deletion of a threonine codon at position 290; and four absent mutations.</text>
                    <arg n="0">two frameshifts and a splice site mutation</arg>
                    <arg n="1">truncated proteins of OA1; a deletion of a threonine codon at position 290; and four absent mutations</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Transduction of the mara region from a sea strain, but not a wild-type strain, leads to the different amino acid terminals.</text>
                    <arg n="0">the different amino acid terminals</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>a complex mutation of the coupling site basic pair G:C is also the strongest determinant in This that leads to an abnormal JAG1 mRNA, resulting in a premature halting codon (Lagrange et al., 1998).</text>
                    <arg n="0">a complex mutation of the coupling site</arg>
                    <arg n="1">an abnormal JAG1 mRNA, resulting in a premature halting codon</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>a complex mutation of the coupling site can lead to an abnormal JNA, resulting in a premature arrest codon.</text>
                    <arg n="0">a complex mutation of the coupling site</arg>
                    <arg n="1">an abnormal JNA, resulting in a premature arrest codon</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>a complex mutation of the coupling site has led in an abnormal JAG1 mRNA, resulting in a premature halting codon, an atypical form of Tay-Sachs disease (GM2 gangliosidosis variant AB).</text>
                    <arg n="0">a complex mutation of the coupling site</arg>
                    <arg n="1">an abnormal JAG1 mRNA, resulting in a premature halting codon</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>a complex mutation of the coupling site led an abnormal JNA, resulting in a premature arrest codon to codify a PTS enzyme IITre for trealose and to codify treC TreC, trealose-6-phosphate-hydroxylase cytoplasmic.</text>
                    <arg n="0">a complex mutation of the coupling site</arg>
                    <arg n="1">an abnormal JNA, resulting in a premature arrest codon</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>a complex mutation of the coupling site may lead to an altered JNA, resulting in a premature arrest codon.</text>
                    <arg n="0">a complex mutation of the coupling site</arg>
                    <arg n="1">an altered JNA, resulting in a premature arrest codon</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>a complex mutation of the coupling site was caused by This which led to an abnormal JNA, resulting in a premature arrest codon.</text>
                    <arg n="0">a complex mutation of the coupling site</arg>
                    <arg n="1">an abnormal JNA, resulting in a premature arrest codon</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>a point mutation at the application site of the third intron, in turn, is leading to ligation of the second to the fourth intron regardless of the DNA binding activity of MEF2.</text>
                    <arg n="0">a point mutation at the application site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth intron</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>a point mutation at the splicing 5 site of the third intron can lead to ligation of the second to the fourth exon, an atypical form of Tay-Sachs disease (gM2 variant of limphosis AB).</text>
                    <arg n="0">a point mutation at the splicing 5 site of the third intron</arg>
                    <arg n="1">ligation of the second to the fourth exon</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S) was led by G979A affects a consensual site of splices at the end of exon 8, and G1488T at exon 14.</text>
                    <arg n="0">G979A affects a consensual site of splices at the end of exon 8, and G1488T at exon 14</arg>
                    <arg n="1">a replacement of a positive charge in a highly conserved putative transmembrane domain (R496S)</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>disorganization of the SNU246 gene in the yeast may lead to in vivo splicing defect, indicating that the protein is essential for splicing (figure 3A).</text>
                    <arg n="0">disorganization of the SNU246 gene in the yeast</arg>
                    <arg n="1">in vivo splicing defect, indicating that the protein is essential for splicing</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>inactivation of the MEF2C gene basic pair G:C is also the strongest determinant in This that led to morphogenetic cardiac defects, vascular abnormalities, and death on the 9.5 embryos (Lagrange et al., 1998).</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities, and death on the 9.5 embryos</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>inactivation of the MEF2C gene may lead to morphogenetic cardiac defects, vascular abnormalities, and death on the 9.5 embryos (figure 3A).</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities, and death on the 9.5 embryos</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>loss of the TreR function was able to lead to derepression of the treB when the cells were grown in rich environments.</text>
                    <arg n="0">loss of the TreR function</arg>
                    <arg n="1">derepression of the treB</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>morphogenetic cardiac defects, vascular abnormalities and lethality per embryonic day 9.5 was led by inactivation of the MEF2C gene.</text>
                    <arg n="0">inactivation of the MEF2C gene</arg>
                    <arg n="1">morphogenetic cardiac defects, vascular abnormalities and lethality per embryonic day 9.5</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>the mutation of the splice at 5 ends of the intron 5 led to the splice in exon 5 and exon 6 (figure 3A).</text>
                    <arg n="0">the mutation of the splice at 5 ends of the intron 5</arg>
                    <arg n="1">the splice in exon 5 and exon 6</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>the mutation of the splice at 5 ends of the intron 5 was caused by This which led to the splice in exon 5 and exon 6.</text>
                    <arg n="0">the mutation of the splice at 5 ends of the intron 5</arg>
                    <arg n="1">the splice in exon 5 and exon 6</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
